The Value Of Complete Blood Count Parameters In The Predicting Lymphovascular Space Invasion in Endometrial Cancer Stage IA Grade 1 And Grade 2 Patients

Abstract

Aim: Evaluation the value of complete blood count parameters to predict lymphovascular space invasion LVSI in the patients with stage 1a G1 / G2 endometrial cancer.Material and Methods: Patients who were operated with the diagnosis of endometrial cancer in our hospital between the years of 2012-2017 and whose tumor was found to be stage 1A G1 / G2 retrospectively studied. A total of 231 patients, including 17 LVSI positive and 214 LVSI negative, were included in the study. The association of LVSI positivity with age, menopausal status, tumor grade, tumor diameter, and complete blood count parameters was assessed.Results: The LVSI positive group and the LVSI negative group were similar in terms of mean age , menopausal status and number of removed lymph nodes. In the LVSI positive group, the mean tumor size was larger and the ratio of G2 tumor was found to be significantly higher respectively p=0,019, p

Keywords

• Mean platelet volume,red cell distribution width,endometrial cancer,lenfovascular space invasion

Endometrium Kanseri Evre IA Grade I Grade 2 Hastalarda Tam Kan Sayımı Parametrelerinin Lenfovasküler Alan İnvazyonunu Öngörmedeki Değeri

Abstract

Amaç: Tam kan sayımı parametrelerinin endometrium kanseri evre 1a G1/G2 hastalarda lenfovasküler alan invazyonunu LVSI öngörmedeki faydasının değerlendirilmesi.Gereç ve Yöntemler: 2012-2017 yılları arasında hastanemizde endometrium kanseri tanısı ile opere edilip evre 1A Grade G 1/2 tümör saptanan hastalar retrospektif olarak incelendi. LVSI pozitif 17, LVSI negatif 214 olmak üzere toplamda 231 hasta çalışmaya dahil edildi. LVSI pozitifliği ile yaş, menapoz durumu, tümör derecesi, tümör çapı ve tam kan sayımı parametrelerinin ilişkisi değerlendirildi.Bulgular: LVSI pozitif grup ile LVSI negatif grup yaş ortalamaları, menapoz durumları, çıkarılan ortalama lenf nodu sayıları açısından benzerdi. LVSI pozitif olan grupta ortalama tümor boyutu daha büyük olup, G2 tümör oranı anlamlı olacak şekilde daha yüksek saptanmıştır sırasıyla p=0,019, p

Keywords

• Ortalama platelet volümü,kırmızı kan hücreleri dağılım genişliği,endometrium kanseri,lenfovasküler alan invazyonu

References

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015 Mar;65(2):87–108.
2. Sorosky JI. Endometrial Cancer. Obstet Gynecol. 2012 Aug;120(2, Part 1): 383–97.
3. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009 May;105(2):103–4.
4. Loizzi V, Cormio G, Lorusso M, Latorre D, Falagario M, Demitri P, et al. The impact of lymph vascular space invasion on recurrence and survival in patients with early stage endometrial cancer. Eur J Cancer Care (Engl). 2014 May;23(3):380–4.
5. Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Leder- mann J, et al. ESMO–ESGO–ESTRO consensus conference on endomet- rial cancer: Diagnosis, treatment and follow-up. Radiother Oncol. 2015 Dec;117(3):559–81.
6. Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med. 1991;91:71–4.
7. Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure: Prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, re- nal function, and nutritional state. Am Heart J. 2009 Oct ;158(4):659–66.
8. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008 Jul 24;454(7203):436–44.

9. Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Platelet size and age determine platelet function independently. 1984;63(6):1372–5.
10. Gu M, Zhai Z, Huang L, Zheng W, Zhou Y, Zhu R, et al. Pre-treatment mean platelet volume associates with worse clinicopathologic features and prognosis of patients with invasive breast cancer. Breast Cancer. 2016 Sep 26;23(5):752–60.
11. Kemal Y, Demirağ G, Ekiz K, Yücel I. Mean platelet volume could be a use- ful biomarker for monitoring epithelial ovarian cancer. J Obstet Gynaecol. 2014 Aug 15 ;34(6):515–8.
12. Goyal H, Hu Z-D. Prognostic value of red blood cell distribution width in hepatocellular carcinoma. Ann Transl Med. 2017 Jul;5(13):271–271.
13. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature . 2008 Jul 24;454(7203):436–44.
14. Zhang Q, Zhu B, Li Y. Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy. Front Immunol. 2017 Feb 2;8:71.
15. Cheng Y-C, Huang C-N, Wu W-J, Li C-C, Ke H-L, Li W-M, et al. The Prognostic Significance of Inflammation-Associated Blood Cell Markers in Patients with Upper Tract Urothelial Carcinoma. Ann Surg Oncol. 2016 Jan 5;23(1):343–51.
16. Wu J, Tan W, Chen L, Huang Z, Mai S. Clinicopathologic and prognostic significance of C-reactive protein/albumin ratio in patients with solid tu- mors: an updated systemic review and meta-analysis. Oncotarget. 2018 Mar 2;9(17):13934–47.
17. Kwon H-C, Kim SH, Oh SY, Lee S, Lee JH, Choi H-J, et al. Clinical signifi- cance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers. 2012 May 17;17(3):216–22.
18. Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure: Prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, re- nal function, and nutritional state. Am Heart J. 2009 Oct;158(4):659–66.
19. Ichinose J, Murakawa T, Kawashima M, Nagayama K, Nitadori J, Anraku M, et al. Prognostic significance of red cell distribution width in elderly patients undergoing resection for non-small cell lung cancer. J Thorac Dis. 2016 Dec;8(12):3658–66.
20. Qin Y, Wu Y, Xian X, Qin J, Lai Z, Liao L, et al. Single and combined use of red cell distribution width, mean platelet volume, and cancer antigen 125 for differential diagnosis of ovarian cancer and benign ovarian tumors. J Ovarian Res. 2018 Dec 22 ;11(1):10.
21. Yang D, Quan W, Wu J, Ji X, Dai Y, Xiao W, et al. The value of red blood cell distribution width in diagnosis of patients with colorectal cancer. Clin Chim Acta. 2018 Apr ;479:98–102.
22. Cheng S, Han F, Wang Y, Xu Y, Qu T, Ju Y, et al. The red distribution width and the platelet distribution width as prognostic predictors in gastric can- cer. BMC Gastroenterol. 2017 Dec 20;17(1):163.
23. Kemal Y, Demirag G, Baş B, Önem S, Teker F, Yücel İ. The value of red blood cell distribution width in endometrial cancer. Clin Chem Lab Med. 2015 Jan;53(5):823–7.
24. Kaushansky. Growth factors and hematopoietic cell fate. A new feature: controversies in hematology. Blood. 1998 Jul 15;92(2):345–4.
25. Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumor Biol. 2016 Sep 3;37(9):11553–72.
26. Oge T, Yalcin OT, Ozalp SS, Isikci T. Platelet volume as a parameter for platelet activation in patients with endometrial cancer. J Obstet Gynaecol. 2013 Apr 3 ;33(3):301–4.
27. Kurtoglu E, Kokcu A, Celik H, Sari S, Tosun M. Platelet Indices May be Useful in Discrimination of Benign and Malign Endometrial Lesions, and Early and Advanced Stage Endometrial Cancer. Asian Pac J Cancer Prev. 2015;16(13):5397–400.